Category: Diabetes
United States Diabetes
-
US Healthcare/Hospital Food Services Market by Type (Patient Dining (Clinical Nutrition, Regular Diet), Retail Services, Vending), Settings (Acute Hospitals, ASC, Long-term care Facilities, Skilled Nursing Facilities, Physician Office) - Forecast to 2029
... been driven by various reasons including the greater emphasis on patient care, higher attention to recovery nutrition, and adherence to dietary regulations. Well-quality, personalized meal plans are being offered by hospitals in large numbers to ... Read More
-
U.S. Sterile Injectables Market, By Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, and Others), By Therapeutic Application (Cancer, Metabolic Disorder, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
... that are administered via various injection routes such as intravenous, intramuscular, subcutaneous, and others in their final sterile form for healing or preventing medical conditions. The rising prevalence of chronic diseases like cancer, diabetes, autoimmune ... Read More
-
U.S. Home Infusion Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... cases of hospital-acquired infections, and a growing aging population are key drivers behind this expansion. Home infusion therapy allows patients to receive medications intravenously or through non-oral routes within their homes. This method is used ... Read More
-
Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis - United States - 2025-2031 - MedSuite - Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more
... market segments, including: Blood Glucose Meters, Blood Glucose Test Strips, Lancets Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM) Insulin & GLP-1 Receptor Agonists (e.g., Ozempic®) Insulin Pens, Insulin Syringes, and Insulin Pumps Key ... Read More
-
The U.S. Medical Weight Loss Market: The Impact of GLP-1s On Doctors, Hospitals, Clinics and Franchises
... There are no medical associations or private sector research firms that cover the small and privately-owned medical weight loss chains, franchises, hospitals and clinics. Marketdata has filled in the gaps with extensive primary research. The ... Read More
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
2024 United States Insulin Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United States Blood Glucose Test Strips Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Glucose Meter Manufacturing in the US - Industry Market Research Report
... The American Diabetes Association (ADA) reports that there are about 8.5 million individuals with undiagnosed diabetes, providing manufacturers with a large potential customer base. Diabetic patients use glucose meters to manage their glucose levels, as ... Read More
-
United States Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Company Analysis 2024-2032 United States Diabetes Device Market Size The United States Diabetes Device market is expected to reach US$ 8.67 Billion in 2023 to US$ 16.25 Billion by 2032, with a CAGR of 7.23 ... Read More
-
United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 – 2032)
... is expected to reach around USD 7,138 million by 2032 poised to grow at a noteworthy CAGR of 6.5% during the forecast period from 2024 to 2032. Market Trends Increased Diabetes Prevalence: The global rise ... Read More
-
United States Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that are driving and restraining the ... Read More
-
US AND Europe Diabetes Associated Eye Disorders Market Research Report Forecast to 2030
... Eye Disorders, also known as Diabetic Eye Diseases, refer to a group of eye conditions that can develop as complications of diabetes, particularly in individuals who have poorly managed blood sugar levels over an extended ... Read More
-
United States In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others] By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F United States in vitro ... Read More
-
Insulin Manufacturing in the US - Industry Market Research Report
... for the treatment of type 1 and type 2 diabetes mellitus. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year ... Read More
-
U.S. Pharma E-commerce Market Size, Share & Trends Analysis Report By Product Type (Vaccines, Specialty Care), By Therapeutic Area (Diabetes, Immune-system Diseases), By Type, By Market Type, By Platform, And Segment Forecasts, 2023 - 2030
... U.S. Pharma E-commerce Market Growth & Trends The U.S. pharma E-commerce market size is anticipated to reach USD 50.77 billion by 2030, growing at a CAGR of 19.8% from 2023 to 2030, according to a ... Read More
-
United States Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 37.69 billion by 2028, at a CAGR of 3.70% during the forecast period (2023-2028). COVID-19 has carved an especially fatal route through the 1 in 10 diabetics in the United States, including ... Read More
-
United States Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... forecast period. Diabetic patients were at a higher risk of hospitalizations and complications during the COVID-19 pandemic due to hyper- or hypoglycemia, metabolic comorbidities, and a more severe SARS-CoV-2 infection.The maintenance of euglycemia was important ... Read More
-
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Landscape & Forecast, 2019–2029 North America Human Insulin Drugs Market Size Grows Steadily to Touch USD 10.3 Billion by 2029 North America human insulin drugs market is flourishing because of an increasing prevalence of type ... Read More
-
United States Autoinjectors Market - By Type (Disposable Autoinjectors, Reusable Autoinjectors); By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies); By Route of Administration (Subcutaneous, Intramuscular); By End User (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Clinics, Ambulatory Surgical Centers, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 United States Autoinjector Market Size Booming to Cross USD 56 Billion by 2029 United States autoinjector market is gaining traction because of the ... Read More
-
United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses ... Read More
-
U.S. Diabetic Neuropathy Market, by Drug (Tricyclic Antidepressants (Amitriptyline, Nortyptyline, Imipramine, Desipramine), SSRI (Paroxetine, Citalopram), Anticonvulsants (Gabapentin, Pregabalin, Carbamazepine), Opioids (Tramadol, Tapentadol, Oksikodon), SNRIs (Duloxetine), Other Drugs (Capsaicin, Lidocaine, Botilinum Toxin)) by Type (Peripheral Neuropathy, Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diabetic neuropathy is ... Read More
-
UNITED STATES DIABETES DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The average number of new COVID-19 cases ... Read More
-
UNITED STATES INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 2.5% over the forecast period. Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The ... Read More
-
UNITED STATES DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... period, 2022-2027. COVID-19 has carved an especially fatal route through the 1 in 10 diabetics in the United States, including those who never contracted the virus. Because, when the epidemic struck, those with the chronic ... Read More
Research Assistance
